The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Are we ready to mitigate time toxicity of cancer care? Oncologists’ perceptions on digital interventions to fast-track cancer care.
 
Erin Mary Bange
Consulting or Advisory Role - Flatiron Health
 
Kerry Q. Coughlin
No Relationships to Disclose
 
Timothy J Brown
No Relationships to Disclose
 
Andrea Bilger
No Relationships to Disclose
 
Eesha Balar
No Relationships to Disclose
 
Dhivya Arasappan
No Relationships to Disclose
 
Michelle Nnaji
No Relationships to Disclose
 
Elise A. Chong
Consulting or Advisory Role - BeiGene; Novartis; TG Therapeutics
Research Funding - Genentech/Roche
 
Pamela Cappucci
No Relationships to Disclose
 
Daniel Ragusano
No Relationships to Disclose
 
Lindsey Joan Zinck
No Relationships to Disclose
 
Adam Fredo
No Relationships to Disclose
 
Caitlin O'Neill
No Relationships to Disclose
 
Wenrui Li
No Relationships to Disclose
 
Mira Mamtani
No Relationships to Disclose
 
Carmen Guerra
Leadership - Freenome; GlaxoSmithKline; GRAIL; Guardant Health
Stock and Other Ownership Interests - BEAM Therapeutics; crispr therapeutics; Editas Medicine; Intellia Therapeutics
Consulting or Advisory Role - AstraZeneca (I)
Speakers' Bureau - Esperion Therapeutics (I); Janssen (I)
Research Funding - Genentech (Inst)
Travel, Accommodations, Expenses - Esperion Therapeutics (I)
 
Ronac Mamtani
Honoraria - Flatiron Health
Consulting or Advisory Role - Bristol Myers Squibb Foundation; Genentech/Roche; Seattle Genetics/Astellas
Research Funding - Merck